SteeleR. Management of missionaries and their families. Infect Med. 1999;16:653-658.
2.
BarnettED. Pediatric travel medicine: challenges for the primary care and travel medicine specialist. Curr Infect Dis Rep. 2013;15:221-226.
3.
BrunetteGW. CDC Health Information for International Travel 2012: The Yellow Book. New York, NY: Oxford University Pres; 2011.
4.
SantoshamMWolffMReidR. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med. 1991;324:1767-1772.
5.
PickeringLKBakerCJKimberlinDWLongSS. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed.Elk Grove Village, IL: American Academy of Pediatrics; 2012.
6.
DobsonSRMcNeilSDionneM. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women. A randomized clinical trial. JAMA. 2013;309:1793-1802.
LevineMMFerreccioCAbregoPMartinOSOrtizECryzS. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine. 1999;17(suppl 2):S22-S27.
9.
RennelsMKingJJrRyallRPapaTFroeschleJ. Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants. Pediatr Infect Dis J. 2004;23:429-435.
10.
SnapeMDPerrettKPFordKJ. Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial. JAMA. 2008;299:173-184.
11.
MackellSM. Vaccinations for the pediatric traveler. Clin Infect Dis. 2003;37:1508-1516.
12.
WildeHBriggsDJMeslinFHemachudhaTSitprijaV. Rabies update for travel medicine advisors. Clin Infect Dis. 2003;37:96-100.
13.
GautretPShawMGazinP. Rabies postexposure prophylaxis in returned injured travelers from France, Australia, and New Zealand: a retrospective study. J Travel Med. 2008;15:25-30.
14.
LeGuerrierPPilonPADeshaiesDAllardR. Pre-exposure rabies prophylaxis for the international traveller: a decision analysis. Vaccine. 1996;14:167-176.
15.
WilkersonJA. Rabies update. Wilderness Environ Med. 2000;11:31-39.
16.
BrownCMCetronM. Crossing borders: one world, global health. Clin Infect Dis. 2011;53(7):iii-v.
17.
SolomonT. Flavivirus encephalitis. N Engl J Med. 2004;351:370-378.
18.
Dubischar-KastnerKKanesa-ThasanN. Vaccinating against Japanese encephalitis virus: what have we learned from recent clinical trials?Expert Rev Vaccines. 2012;11:1159-1161.
19.
BellBPNegusSFioreAE. Immunogenicity of an inactivated hepatitis A vaccine in infants and young children. Pediatr Infect Dis J. 2007;26:116-122.
20.
TroisiCLBlaine HollingerFKrauseDSPickeringLK. Immunization of seronegative infants with hepatitis A vaccine (HAVRIX®; SKB): a comparative study of two dosing schedules. Vaccine. 1997;15:1613-1617.
21.
StaufferWMKamatD. Traveling with infants and children. Part 2: immunizations. J Travel Med. 2002;9:82-90.
22.
PlourdePJ. Travellers’ diarrhea in children. Paediatr Child Health. 2003;8:99-103.
23.
FischerPRBialekR. Prevention of malaria in children. Clin Infect Dis. 2002;34:493-498.
24.
TanKRMagillAJPariseMEArguinPM; Centers for Disease Control and Prevention. Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg. 2011;84:517-531.